On Jan. 05, Villiger Walter divested U.S. $2,618,613 in shares of BioLife Solutions Inc.. The 10% sold 64,023 shares at a price per share of $40.90. The transaction decreased this specific insider’s holdings to 3,619,234 shares worth around $147.66 million at present.
KeyBanc Capital Markets launched its BioLife Solutions Inc. [BLFS] rating to the equivalent of an Overweight and assigned the price target of $40, in a research note dated November 10, 2020. That figure represents around a -2.0% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with KeyBanc Capital Markets’s analysts assigning the shares to “an Overweight” rating in a research note to investors issued in early November. Meanwhile, Oppenheimer had lowered its rating on BLFS to “Perform” from the earlier “an Outperform”, in a research note produced for clients September 22, 2020. In addition, there was a new coverage from Cowen on September 18, 2020. The research firm rated BLFS “an Outperform”.
Is BioLife Solutions Inc. [NASDAQ:BLFS] a Good Buy Right Now?
It should be noted that BLFS technical indicators for short, intermediate as well as long term progress have placed an overall average of 80% as Buy. The average signal changed from 80% Buy in the last week and compares with 100% Buy in the past month. Data from BioLife Solutions Inc.’s Trend Spotter indicated that the signals were Falling. The stock current average is 0.32 million shares in the past 20 days and the short term average signal indicates a 50% Buy. In the last 50 days, the average trading volume was 0.34 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.33 million shares.
BLFS Price Performance
On Wall Street, BioLife Solutions Inc. [NASDAQ:BLFS] finished Friday’s session down -0.41% at $40.80. The stock went up to $41.58 at the same session while its lowest single day price was $38.75. In the last five days, it saw a rise of about 2.28%, BioLife Solutions Inc. shares gained by almost 2.28% since the beginning of the year. However, the share price has dropped to as low as -13.59% below its one year high. On 01/05/21, the company shares recorded $43.35, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/07/21, the same year at $37.80. The company’s shares have inclined by 139.58% in the past year. The 50-day SMA achieved is $36.87 while the 200-day SMA is $23.39. Volume dropped to 0.33 million from 0.39 million in the previous session.
BLFS Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 39.17 level, and in case of violation of this particular level, it will cause more drop to 37.55 level. On the upper level, 43.21 is still the key resistance. The stock may increase to the subsequent resistance at 42.00. The Relative Strength Index (RSI) pinned on the 14-day chart is 52.26, implying a neutral technical stance while the MACD stands at -1.87, meaning price will decrease in the next trading period. Percent R indicator moved to 68.14%, implying low price movement. Stochastic %K at 24.23% suggest holding the stock.
What is the short interest in BioLife Solutions Inc.?
Short interest in the BioLife Solutions Inc. stock has surged, increasing by 0.38 million shares to total 0.98 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 1.36 million, data from Yahoo Finance shows. The decrease of -39.3% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 3.90% of the overall float for the stock.
BioLife Solutions Inc.’s Biggest Shareholders: Who Owns BioLife Solutions Inc. [BLFS]?
Filings by Casdin Capital LLC showed that the firm now holds a total of 7,440,107 shares or roughly 22.73% of the outstanding BLFS shares. This means their shares have increased by 1,600,000 from the 7,440,107 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Wasatch Advisors, Inc. updated stake is worth $61,791,771. Details in the latest 13F filings reveal that The Vanguard Group, Inc. acquired their 49.45% stake valued at $40,953,489 while Ranger Investment Management LP added theirs at $40,810,968. During the last quarter, The Vanguard Group, Inc. raised 376,525 of its shares in BioLife Solutions Inc. while Ranger Investment Management LP bought 671,377 shares. The BlackRock Fund Advisors’s holdings currently number 1,028,261 shares at $41953048.8. According to the firm’s last 13F report, Park West Asset Management LLC shares in the company at filing stood at 966,045 shares, roughly $34,767,960.
BLFS Earnings Forecast For The Current Quarter
BioLife Solutions Inc. [BLFS] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $13.5M and an earnings per share of -$0.02 for Dec 2020. Looking further ahead, the company is expected to report revenue of $15.59M at an EPS of $0 for Mar 2021. The estimates represent upside of 48.20% and -52.63% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
BLFS Earnings Estimates For The Current Year
For the financial year, BioLife Solutions Inc. [NASDAQ:BLFS] is expected to bring in revenue of $46.87M. The returns are nearly $19.5 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0.19, lower than that of FY19 by -$0.23. Estimates put this year’s earnings growth at -54.80%, -52.60% for the next, and at an annual 10.00% over the next 5-year period. As for sales, forecasts are for an increase of 71.20% in the current fiscal year and a further 48.20% over the following year.
What are analyst thoughts on BioLife Solutions Inc.?
Looking forward to the BioLife Solutions Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for BioLife Solutions Inc. stock at $40.00 within the next 12 months, which represents almost -2.0 per cent growth from its previous closing price of $40.80. The highest analysts’ target for BioLife Solutions Inc. stock projections is $55.00 and the lowest one is $35.50. Still, 9 analysts sharing their consensus rating for BLFS stock in 2021 agree that it is a Buy.